Company / Working Capital
Tango Therapeutics, Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$332.1M
FY2025
5-year range
$228.2M / $451.6M
FY2021-FY2025
Trend
+45.5%
vs FY2024
Sector context
#129 of 213
Health Care
What the data says
At $332M, Tango Therapeutics, Inc.'s working capital ranks #129 of 213 in the Health Care sector. Working Capital returned to growth in FY2025 after 3 years of decline, reaching $332M.
Based on SEC 10-K filings.
$332M in FY2025 with a 5-year CAGR of +16.8%.
Improved from $301M to $332M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +1.3%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
#129 of 213 in Health CareTop 61% of 213This company $332.1M Sector average $934.6M
▼
-64.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.8%, indicating consistent growth.
- In FY2025, working capital increased 45.5% year-over-year.
- Ranks #129 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $332.1M | +45.5% |
| FY2024 | $228.2M | -24.1% |
| FY2023 | $300.6M | -6.0% |
| FY2022 | $319.7M | -29.2% |
| FY2021 | $451.6M | +195.7% |
| FY2020 | $152.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026